UroGen Pharma reported cash from operations of -$33.01M and free cash flow of -$34.27M for the quarter ended Jun 2026, up 17.1% year over year. This cash flow statement covers 39 quarters of results from Dec 2016 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||||||||||||||||
| Net Income | -30.21M | -1.85M | -28.39M | -26.69M | -25.83M | -2.27M | -30.21M | -24.14M | -21.88M | 0.52M | -32.29M | -33.40M | -23.67M | -6.15M | -43.84M | -49.94M | -33.35M | 9.00M | -23.57M | -14.35M | |||||||||||||||||||
| Share-based CompensationStock Comp. | 5.51M | 5.36M | 2.95M | 2.82M | 2.44M | 2.37M | 2.29M | 2.22M | 2.22M | 2.61M | 2.76M | 3.56M | 3.49M | 3.30M | 3.07M | 2.73M | 17.60M | 3.13M | 39.10M | 39.00M | |||||||||||||||||||
| Gains from Investment SecuritiesGains Investment | |||||||||||||||||||||||||||||||||||||||
| Asset Writedowns and ImpairmentWritedown | 0.35M | 0.26M | |||||||||||||||||||||||||||||||||||||
| Cash from OperationsCash from Ops. | -18.48M | -20.07M | -24.00M | -24.20M | -17.61M | -21.75M | -25.81M | -20.27M | -17.30M | -13.00M | -31.73M | -23.75M | -27.66M | -13.62M | -42.02M | -39.83M | -42.27M | -38.33M | -45.32M | -33.01M | |||||||||||||||||||
| Depreciation, Depletion & Amortization | |||||||||||||||||||||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 0.23M | 0.24M | 0.28M | 0.20M | 0.59M | 0.68M | 0.40M | 0.35M | 0.22M | 0.05M | -0.96M | 0.22M | 2.29M | 1.34M | 0.77M | 0.87M | 0.16M | 0.30M | 1.97M | -0.80M | |||||||||||||||||||
| Amortization of Deferred ChargesAmort. Deferred Charges | |||||||||||||||||||||||||||||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.20M | 0.21M | 0.21M | 0.20M | 0.20M | 0.22M | 0.22M | 0.20M | 0.20M | 0.19M | 0.12M | 0.10M | 0.10M | 0.03M | 0.10M | 0.10M | 0.10M | 0.07M | 0.10M | 0.10M | |||||||||||||||||||
| Change in Working Capital | |||||||||||||||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | -1.73M | 3.93M | -2.22M | 2.10M | -2.17M | 3.27M | -0.21M | 3.01M | -2.66M | 2.60M | -1.28M | 3.26M | 5.39M | -2.50M | -0.66M | 0.01M | 0.05M | 13.38M | 22.33M | 33.34M | |||||||||||||||||||
| Change in InventoryChange Inventory | 0.39M | 1.02M | -0.08M | 0.56M | 0.17M | -0.28M | 1.14M | -0.48M | 0.01M | 0.67M | 1.57M | 0.20M | 0.15M | 1.63M | -1.64M | -0.46M | 1.21M | 8.12M | 4.46M | 3.67M | |||||||||||||||||||
| Change in Accured ExpensesChange Accured Exp. | -0.30M | 0.47M | -2.17M | -1.28M | 0.71M | 4.05M | 4.75M | -0.73M | -2.32M | 2.46M | -5.83M | 13.04M | -4.07M | 7.75M | -3.60M | 7.13M | -4.79M | 4.20M | 7.63M | 4.60M | |||||||||||||||||||
| Investing Activities | |||||||||||||||||||||||||||||||||||||||
| Capital ExpendituresCapex | 0.55M | -0.55M | 0.17M | 0.28M | 0.56M | 0.27M | 0.42M | -0.34M | -0.77M | -0.01M | -0.94M | -0.42M | -0.30M | 0.22M | -0.22M | 0.43M | 5.96M | -1.60M | 2.33M | 1.27M | |||||||||||||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 18.33M | 9.63M | 13.62M | -0.09M | 27.67M | 23.12M | 30.47M | 3.73M | 11.33M | 3.54M | 13.52M | 12.08M | 12.14M | 69.97M | 40.43M | 30.34M | 40.21M | 28.27M | 4.15M | 1.73M | |||||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | 10.66M | 9.12M | 13.60M | -0.15M | -35.49M | 23.11M | 6.27M | 3.72M | 0.40M | -11.34M | 13.52M | 12.00M | -106.75M | 60.62M | -25.96M | 28.41M | 31.40M | 27.72M | -20.69M | 1.67M | |||||||||||||||||||
| Financing Activities | |||||||||||||||||||||||||||||||||||||||
| Other financing activitiesOther financing | 0.00M | 0.02M | 1.12M | 0.38M | 0.67M | 0.14M | 47.89M | 18.64M | 0.03M | 0.30M | 0.30M | 1.34M | 0.18M | 0.89M | |||||||||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | -0.17M | -0.03M | 70.74M | -0.08M | 1.10M | 25.37M | 0.67M | 0.14M | 116.08M | 0.04M | 54.66M | 100.28M | 39.61M | 0.07M | 0.03M | 0.30M | 8.27M | 31.32M | 65.20M | 0.50M | |||||||||||||||||||
| Change in Capital Stock | |||||||||||||||||||||||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 0.59M | 0.41M | 0.53M | 0.28M | 0.12M | ||||||||||||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 67.36M | 54.66M | 81.51M | 15.00M | 0.00M | -0.00M | 8.20M | 31.83M | |||||||||||||||||||||||||||||||
| Additional items | |||||||||||||||||||||||||||||||||||||||
| Change in Cash | -7.98M | -10.98M | 60.34M | -24.43M | -52.00M | 26.72M | -18.87M | -16.41M | 99.18M | -24.30M | 36.44M | 88.53M | -94.81M | 47.07M | -67.95M | -11.12M | -2.60M | 20.71M | -0.80M | -30.83M | |||||||||||||||||||
| Free Cash FlowFCF | -19.02M | -19.52M | -24.16M | -24.47M | -18.17M | -22.02M | -26.23M | -19.93M | -16.53M | -12.98M | -30.80M | -23.32M | -27.36M | -13.84M | -41.81M | -40.26M | -48.23M | -36.73M | -47.65M | -34.27M | |||||||||||||||||||
| Net Cash FlowNCF | -7.98M | -10.98M | 60.34M | -24.43M | -52.00M | 26.72M | -18.87M | -16.41M | 99.18M | -24.30M | 36.44M | 88.53M | -94.81M | 47.07M | -67.95M | -11.12M | -2.60M | 20.71M | -0.80M | -30.83M |